Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Reich

Showing results (1-10 of 265) with videos related to

Pageof 27
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 24, 2016
Dr. Kurt und Eva Herrmann-Stipendium in Höhe von 10 000 Euro für junge Dermatologinnen/DermatologenKristian Reich
The New England Journal of Medicine|July 20, 2012
Anti-interleukin-17 monoclonal antibody ixekizumab in psoriasisKristian Reich
The New England Journal of Medicine|September 13, 2013
Case reports of PML in patients treated for psoriasisUlrich Mrowietz, Kristian Reich
Zeitschrift Fur Rheumatologie|June 8, 2013
[Skin as manifestation organ for inflammatory rheumatic diseases]Jürgen Wollenhaupt, Kristian Reich
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 3, 2017
Arzneimittelsicherheit bei Psoriasis: Welche Rolle spielt Suizidalität?Kristian Reich, Matthias Augustin
European Journal of Pharmacology|October 20, 2009
Ten years of infliximab: its role in dermatologyUlrich Mrowietz, Kristian Reich
Deutsches Arzteblatt International|July 1, 2009
Psoriasis--new insights into pathogenesis and treatmentUlrich Mrowietz, Kristian Reich
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 6, 2007
Treatment goals in psoriasisKristian Reich, Ulrich Mrowietz
Medizinische Monatsschrift Fur Pharmazeuten|October 3, 2009
[Psoriasis--clinical picture and current therapy]Kaweh Shakery, Kristian Reich
Current Problems in Dermatology|August 28, 2009
Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximabRotraut Mössner, Kristian Reich
Pageof 27

Showing results (1-10 of 265) with videos related to

Sort By:
Pageof 27
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 24, 2016
Dr. Kurt und Eva Herrmann-Stipendium in Höhe von 10 000 Euro für junge Dermatologinnen/DermatologenKristian Reich
The New England Journal of Medicine|July 20, 2012
Anti-interleukin-17 monoclonal antibody ixekizumab in psoriasisKristian Reich
The New England Journal of Medicine|September 13, 2013
Case reports of PML in patients treated for psoriasisUlrich Mrowietz, Kristian Reich
Zeitschrift Fur Rheumatologie|June 8, 2013
[Skin as manifestation organ for inflammatory rheumatic diseases]Jürgen Wollenhaupt, Kristian Reich
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 3, 2017
Arzneimittelsicherheit bei Psoriasis: Welche Rolle spielt Suizidalität?Kristian Reich, Matthias Augustin
European Journal of Pharmacology|October 20, 2009
Ten years of infliximab: its role in dermatologyUlrich Mrowietz, Kristian Reich
Deutsches Arzteblatt International|July 1, 2009
Psoriasis--new insights into pathogenesis and treatmentUlrich Mrowietz, Kristian Reich
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 6, 2007
Treatment goals in psoriasisKristian Reich, Ulrich Mrowietz
Medizinische Monatsschrift Fur Pharmazeuten|October 3, 2009
[Psoriasis--clinical picture and current therapy]Kaweh Shakery, Kristian Reich
Current Problems in Dermatology|August 28, 2009
Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximabRotraut Mössner, Kristian Reich
Pageof 27